Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM RegistryVanessa E. Kennedy, Hanneke Oude Elberink, Knut Brockow et al.|Blood Advances|2022Cited by 39
Comprehensive response criteria for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working GroupWilliam Shomali, Jason Gotlib, Jean‐Jacques Kiladjian et al.|Leukemia|2023Cited by 14
Pemigatinib for Myeloid/Lymphoid Neoplasms with <i>FGFR1</i> RearrangementSrđan Verstovšek, Jason Gotlib, Stephen T. Oh et al.|NEJM Evidence|2025Cited by 7